Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations

Dis Model Mech. 2021 Aug 1;14(8):dmm049070. doi: 10.1242/dmm.049070. Epub 2021 Aug 31.

Abstract

Our understanding of the aetiology and pathophysiology of endometriosis remains limited. Disease modelling in the field is problematic as many versions of induced mouse models of endometriosis exist. We integrated bioluminescent imaging of 'lesions' generated using luciferase-expressing donor mice. We compared longitudinal bioluminescence and histology of lesions, sensory behaviour of mice with induced endometriosis and the impact of the gonadotropin-releasing hormone antagonist Cetrorelix on lesion regression and sensory behaviour. Four models of endometriosis were tested. We found that the nature of the donor uterine material was a key determinant of how chronic the lesions were, as well as their cellular composition. The severity of pain-like behaviour also varied across models. Although Cetrorelix significantly reduced lesion bioluminescence in all models, it had varying impacts on pain-like behaviour. Collectively, our results demonstrate key differences in the progression of the 'disease' across different mouse models of endometriosis. We propose that validation and testing in multiple models, each of which may be representative of the different subtypes/heterogeneity observed in women, should become a standard approach to discovery science in the field of endometriosis.

Keywords: Endometriosis; GnRH antagonist; Lesion; Pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Endometriosis* / diagnostic imaging
  • Endometriosis* / pathology
  • Female
  • Hormone Antagonists / pharmacology
  • Humans
  • Mice

Substances

  • Hormone Antagonists